Wang Juan, Vodovotz Yoram, Fan Liyan, Li Yuehua, Liu Zheng, Namas Rami, Barclay Derek, Zamora Ruben, Billiar Timothy R, Wilson Mark A, Fan Jie, Jiang Yong
State Key Laboratory of Organ Failure Research, Key Laboratory of Transcriptomics and Proteomics, Ministry of Education of China, Key Laboratory of Proteomics of Guangdong Province, Southern Medical University, Guangzhou, China; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA;
Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
FASEB J. 2015 Jan;29(1):250-62. doi: 10.1096/fj.14-255992. Epub 2014 Oct 23.
Trauma/hemorrhagic shock is associated with morbidity and mortality due to dysregulated inflammation, which is driven in part by monocytes/macrophages stimulated by injury-induced release of damage-associated molecular pattern (DAMP) molecules. MRP8/MRP14 is an endogenous DAMP involved in various inflammatory diseases, though its mechanism of action is unclear. Circulating MRP8/MRP14 levels in human blunt trauma nonsurvivors were significantly lower than those of survivors (P < 0.001). Human monocytic THP-1 cells stimulated with MRP8/MRP14 expressed the chemokine IFN-γ inducible protein 10 (IP-10)/CXCL10. Circulating IP-10 levels in human blunt trauma patients were correlated positively with MRP8/MRP14 levels (r = 0.396, P < 0.001), and were significantly lower in trauma nonsurvivors than in survivors (P < 0.001). We therefore sought to determine the mechanisms by which MRP8/MRP14 stimulates IP-10 in monocytes/macrophages, and found that induction of IP-10 by MRP8/MRP14 required Toll-like receptor 4 and TRIF but not MyD88. Full induction of IP-10 by MRP8/MRP14 required synergy between the transcription factors NF-κB and IFN regulatory factor 3 (IRF3). The receptor for IP-10 is CXCR3, and MRP8/MRP14-induced chemotaxis of CXCR3(+) cells was dependent on the production of IP-10 in monocytes/macrophages. Furthermore, in vivo study with a mouse trauma/hemorrhagic shock model showed that administration of neutralizing antibody against MRP8 prevented activation of NF-κB and IRF3 as well as IP-10 production. Thus, the current study identified a novel signaling mechanism that controls IP-10 expression in monocytes/macrophages by MRP8/MRP14, which may play an important role in injury-induced inflammation.
创伤/失血性休克与炎症调节异常导致的发病率和死亡率相关,炎症调节异常部分是由损伤诱导释放的损伤相关分子模式(DAMP)分子刺激单核细胞/巨噬细胞所驱动。MRP8/MRP14是一种参与多种炎症性疾病的内源性DAMP,但其作用机制尚不清楚。人类钝性创伤非幸存者的循环MRP8/MRP14水平显著低于幸存者(P < 0.001)。用MRP8/MRP14刺激的人单核细胞THP-1细胞表达趋化因子γ干扰素诱导蛋白10(IP-10)/CXCL10。人类钝性创伤患者的循环IP-10水平与MRP8/MRP14水平呈正相关(r = 0.396,P < 0.001),创伤非幸存者的该水平显著低于幸存者(P < 0.001)。因此,我们试图确定MRP8/MRP14刺激单核细胞/巨噬细胞中IP-10的机制,发现MRP8/MRP14诱导IP-10需要Toll样受体4和TRIF,但不需要MyD88。MRP8/MRP14对IP-10的完全诱导需要转录因子NF-κB和干扰素调节因子3(IRF3)之间的协同作用。IP-10的受体是CXCR3,MRP8/MRP14诱导的CXCR3(+)细胞趋化性依赖于单核细胞/巨噬细胞中IP-10的产生。此外,在小鼠创伤/失血性休克模型的体内研究表明,给予抗MRP8中和抗体可阻止NF-κB和IRF3的激活以及IP-10的产生。因此,本研究确定了一种新的信号传导机制,即MRP8/MRP14控制单核细胞/巨噬细胞中IP-10的表达,这可能在损伤诱导的炎症中起重要作用。